HomeXBIO • NASDAQ
Xenetic Biosciences Inc
add
$10.36
141.49%
After Hours:(0.00%)0.00
$10.36
Closed: Oct 8, 5:32:27 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 589.90K | -18.79% |
Operating expense | 1.31M | -36.32% |
Net income | -688.70K | 45.94% |
Net profit margin | -116.75 | 33.43% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.78M | -34.51% |
Total assets | 5.35M | -40.73% |
Total liabilities | 903.43K | -43.09% |
Total equity | 4.45M | — |
Shares outstanding | 1.54M | — |
Price to book | 1.49 | — |
Return on assets | -32.50% | — |
Return on capital | -37.83% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -688.70K | 45.94% |
Cash from operations | -383.83K | 26.90% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -383.83K | 26.90% |
Free cash flow | -461.81K | -430.77% |
Previous close
$4.29
Day range
$9.34 - $13.93
Year range
$2.20 - $13.93
Market cap
15.98M USD
Avg Volume
24.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1997
Headquarters
Website
Employees
2
